PAMS
ONC

Pinpoint Asset Management (Singapore)’s BeOne Medicines Ltd ONC Stock Holding History

Pinpoint Asset Management (Singapore)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85M Buy
9,610
+5,236
+120% +$1.69M 0.66% 27
2025
Q4 		$1.33M Hold
4,374
– – 0.28% 31
2025
Q3 		$1.49M Sell
4,374
-11,926
-73% -$3.62M 0.27% 40
2025
Q2 		$3.95M Buy
+16,300
New +$4M 0.69% 27

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pinpoint Asset Management (Singapore)'s ONC Position: Q1 2026 in Review

Pinpoint Asset Management (Singapore) increased its BeOne Medicines Ltd (ONC) stake by 120% in Q1 2026, buying an estimated $1.69M and bringing the position to 9,610 shares worth $2.85M. The position accounts for 0.66% of the portfolio, ranked #27.

Pinpoint Asset Management (Singapore) first reported a position in ONC in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.95M in Q2 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Pinpoint Asset Management (Singapore) held 9,610 shares of BeOne Medicines Ltd worth $2.85M as of Q1 2026.
  • Pinpoint Asset Management (Singapore) bought 5,236 BeOne Medicines Ltd shares in Q1 2026, an estimated $1.69M.
  • BeOne Medicines Ltd made up 0.66% of Pinpoint Asset Management (Singapore)'s portfolio in Q1 2026, its #27 holding.
  • Pinpoint Asset Management (Singapore) first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 4 quarters since.
  • Pinpoint Asset Management (Singapore)'s BeOne Medicines Ltd position peaked at $3.95M in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Pinpoint Asset Management (Singapore)'s 13F filing for Q1 2026, filed 13 May 2026.